[1] |
NI Jiachun, CAI Zengjin, HOU Changcheng, JIANG Qiong, KANG Jian, YANG Xiangdong, FAN Wenbin.
Hemorrhoidal Disease Classification Methods: Recent Advances and Value Analysis
[J]. Chinese General Practice, 2024, 27(20): 2545-2550.
|
[2] |
LI Mengye, JIANG Yinong.
Recent Advances in Soluble Prorenin Receptor in Multisystem Diseases
[J]. Chinese General Practice, 2024, 27(18): 2295-2300.
|
[3] |
KANG Yinnan, SHI Jiaqi, WANG Junke, LI Bin, LI Chuyi, MA Jun, YU Xiaohui.
Advances in the Application of Antibody Drug Conjugate in Gastric Cancer with Low Expression of Human Epidermal Growth Factor Receptor 2
[J]. Chinese General Practice, 2024, 27(18): 2287-2294.
|
[4] |
JIANG Qixia, XIE Haoting, WANG Huajun, LI Xiuyun, ZHU Yuling, WANG Yaling, MIN Yan, WANG Ke.
Effectiveness Analysis of Two Incontinence Care Plans Based on Guidelines for Elderly COVID-19 Patients with Incontinence
[J]. Chinese General Practice, 2024, 27(18): 2212-2217.
|
[5] |
MIAO Lipeng, REN Kehao, LI Mengdie, LYU Juncheng.
Trend Analysis and Prediction of Cardiovascular Disease Mortality in China from 2009 to 2021
[J]. Chinese General Practice, 2024, 27(18): 2260-2264.
|
[6] |
LI Jingjing, ZHENG Gaigai, WANG Yu, LIU Yancun, ZHANG Shuangqi, YANG Qiaofang.
A Systematic Review of Symptom Assessment Tools for Patients with Heart Failure
[J]. Chinese General Practice, 2024, 27(18): 2272-2278.
|
[7] |
XUE Yanan, OU Minxing, ZHANG Xiujie, MENG Qingxue, LIU Ying.
Interpretation of Key Points of 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients with Chronic Coronary Disease
[J]. Chinese General Practice, 2024, 27(18): 2173-2178.
|
[8] |
Primary Healthcare and Health Education Committee of the Guangdong Provincial Health Management Association, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine.
Expert Recommendations on the Diagnosis, Treatment, and Care of Post-COVID-19 Conditions for Primary Health Services: Guangdong Province
[J]. Chinese General Practice, 2024, 27(17): 2045-2063.
|
[9] |
YANG Xu, YAO Mi.
Interpretation of the U.S. Preventive Clinical Services Guidelines Workgroup's Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions
[J]. Chinese General Practice, 2024, 27(17): 2064-2069.
|
[10] |
XU Ziwei, CHENG Kangyao, GUI Li.
A Scoping Review of Research on the Management of Surge Hospitals during a Major Infectious Disease Outbreak
[J]. Chinese General Practice, 2024, 27(16): 2039-2044.
|
[11] |
NI Xuetong, WANG Ruoxi, ZHANG Jing, YANG Xinghua.
Research Progress in the Correlation of Non-alcoholic Fatty Liver Disease and Metabolic-associated Fatty Liver Disease with Cardiovascular Diseases in China and Abroad
[J]. Chinese General Practice, 2024, 27(16): 2033-2038.
|
[12] |
LI Zidong, ZHU Lin.
Clinical Characteristics and Risk Factors of Fatigue in COVID-19 during Recovery Period
[J]. Chinese General Practice, 2024, 27(15): 1849-1854.
|
[13] |
WANG Fangfang, ZHU Li, XING Jiajia, PANG Rizhao, GOU Xiang, ZHANG Anren.
Research Progress on the Changes of Intestinal Barrier and Possible Mechanism after Traumatic Central Nervous System Injury
[J]. Chinese General Practice, 2024, 27(14): 1775-1781.
|
[14] |
CAO Jiacen, ZHANG Hongkun, ZHAO Wen, NAN Yuemin, LI Dongdong.
Progress of Heme Oxygenase-1 Mediated Ferroptosis in Non-alcoholic Fatty Liver Disease
[J]. Chinese General Practice, 2024, 27(14): 1782-1788.
|
[15] |
DU Shuqin, QIAN Lifeng, XIONG Lie, SHI Hanqiang, SHI Yanbo.
Ferroptosis: a New Target for the Treatment of Depressive Disorder
[J]. Chinese General Practice, 2024, 27(12): 1417-1423.
|